skip to main content

H.R. 4400 (114th): Adding Zika Virus to the FDA Priority Review Voucher Program Act

Compare this bill to another bill:

React to this bill with an emoji

(About Ads | Hide These Ads)

The text of the bill below is as of Feb 1, 2016 (Introduced). The bill was not enacted into law.

I

114th CONGRESS

2d Session

H. R. 4400

IN THE HOUSE OF REPRESENTATIVES

February 1, 2016

(for himself and Mrs. Brooks of Indiana) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.

1.

Short title

This Act may be cited as the Adding Zika Virus to the FDA Priority Review Voucher Program Act.

2.

Expanding tropical disease product priority review voucher program to encourage treatments for Zika virus

Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n) is amended—

(1)

by redesignating subparagraph (R) as subparagraph (S); and

(2)

by inserting after subparagraph (Q) the following:

(R)

Zika virus.

.